Nowotnick Adrian G, Xi Zhongqian, Jin Zhaorui, Khalatbarizamanpoor Sadaf, Brauer Delia S, Löffler Bettina, Jandt Klaus D
Chair of Materials Science (CMS), Otto Schott Institute of Materials Research (OSIM), Friedrich Schiller University Jena, Löbdergraben 32, 07743, Jena, Germany.
Jena School for Microbial Communication (JSMC), 07743, Neugasse 23, Jena, Germany.
Adv Healthc Mater. 2024 Dec;13(32):e2402001. doi: 10.1002/adhm.202402001. Epub 2024 Sep 20.
Developing effective antimicrobial biomaterials is a relevant and fast-growing field in advanced healthcare materials. Several well-known (e.g., traditional antibiotics, silver, copper etc.) and newer (e.g., nanostructured, chemical, biomimetic etc.) approaches have been researched and developed in recent years and valuable knowledge has been gained. However, biomaterials associated infections (BAIs) remain a largely unsolved problem and breakthroughs in this area are sparse. Hence, novel high risk and potential high gain approaches are needed to address the important challenge of BAIs. Antibiotic free antimicrobial biomaterials that are largely based on physical action are promising, since they reduce the risk of antibiotic resistance and tolerance. Here, selected examples are reviewed such antimicrobial biomaterials, namely switchable, protein-based, carbon-based and bioactive glass, considering microbiological aspects of BAIs. The review shows that antimicrobial biomaterials mainly based on physical action are powerful tools to control microbial growth at biomaterials interfaces. These biomaterials have major clinical and application potential for future antimicrobial healthcare materials without promoting microbial tolerance. It also shows that the antimicrobial action of these materials is based on different complex processes and mechanisms, often on the nanoscale. The review concludes with an outlook and highlights current important research questions in antimicrobial biomaterials.
开发有效的抗菌生物材料是先进医疗材料领域中一个相关且快速发展的领域。近年来,人们对几种知名方法(如传统抗生素、银、铜等)和新方法(如纳米结构、化学、仿生等)进行了研究和开发,并获得了宝贵的知识。然而,生物材料相关感染(BAIs)仍然是一个基本上未解决的问题,该领域的突破很少。因此,需要新颖的高风险和潜在高收益方法来应对BAIs这一重要挑战。主要基于物理作用的无抗生素抗菌生物材料很有前景,因为它们降低了抗生素耐药性和耐受性的风险。在此,考虑到BAIs的微生物学方面,对这类抗菌生物材料的选定实例进行了综述,即可切换的、基于蛋白质的、基于碳的和生物活性玻璃。综述表明,主要基于物理作用的抗菌生物材料是控制生物材料界面微生物生长的有力工具。这些生物材料在未来抗菌医疗材料方面具有重大的临床和应用潜力,且不会促进微生物耐受性。它还表明,这些材料的抗菌作用基于不同的复杂过程和机制,通常是在纳米尺度上。综述最后展望了未来,并强调了抗菌生物材料当前的重要研究问题。